Updated 2026-09-03 · NCT07684235See eligibility →
City
Clinical trials near Arlington, United States
Active studies with a listed research site in Arlington, United States.
11active studies
3recruiting now
9countries represented
137largest site network
Current studies
Status and location data reflect the registry snapshot built 2026-09-08. Verify the original record before contacting a site.
Updated 2026-09-03 · NCT07752979See eligibility →
Updated 2026-08-17 · NCT07575932See eligibility →
Updated 2026-08-25 · NCT07720271See eligibility →
Updated 2026-07-24 · NCT07011667See eligibility →
Active, not recruitingPhase 2
Study to Evaluate HM15275 in Obese or Overweight Subjects Without Diabetes Mellitus
Updated 2026-04-08 · NCT07205900See eligibility →
Active, not recruitingPhase 3
VK2735 for Weight Management Type 2 Diabetes Phase 3 (VANQUISH 2)
Updated 2026-04-07 · NCT07104383See eligibility →
Active, not recruitingPhase 2
Taldefgrobep Alfa in Adults With Overweight and Obesity
Updated 2026-03-20 · NCT07281495See eligibility →
Active, not recruitingNot applicable
Arlington Longitudinal Optimal Healthy Aging Study (ALOHA)
Updated 2026-03-09 · NCT07180147See eligibility →
Active, not recruitingPhase 3
A Research Study to Look Into the Long-term Effect on Weight Loss of CagriSema in People With Obesity
Updated 2026-01-20 · NCT06780449See eligibility →
Active, not recruitingPhase 3
VK2735 for Weight Management Phase 3
Updated 2025-11-24 · NCT07104500See eligibility →
Related cities
Beijing, China123Boston, United States76Houston, United States75Shanghai, China74Chicago, United States70New York, United States59
How current is this page?
The page is rebuilt from the public registry feed. Each trial card shows the registry update date. Recruitment can still change between builds.
Does appearing here mean I qualify?
No. These pages are discovery indexes. Only a study team can confirm eligibility after reviewing the complete protocol criteria.